Zacks: Brokerages Anticipate QuinStreet Inc (QNST) Will Post Earnings of $0.12 Per Share

Share on StockTwits

Analysts forecast that QuinStreet Inc (NASDAQ:QNST) will post $0.12 earnings per share for the current quarter, according to Zacks Investment Research. Four analysts have made estimates for QuinStreet’s earnings, with the highest EPS estimate coming in at $0.13 and the lowest estimate coming in at $0.12. QuinStreet reported earnings of $0.07 per share during the same quarter last year, which indicates a positive year over year growth rate of 71.4%. The business is expected to announce its next earnings results on Wednesday, January 30th.

According to Zacks, analysts expect that QuinStreet will report full year earnings of $0.65 per share for the current fiscal year, with EPS estimates ranging from $0.60 to $0.70. For the next financial year, analysts expect that the company will report earnings of $0.86 per share, with EPS estimates ranging from $0.80 to $0.95. Zacks Investment Research’s EPS averages are an average based on a survey of analysts that follow QuinStreet.

QuinStreet (NASDAQ:QNST) last released its quarterly earnings data on Tuesday, October 30th. The technology company reported $0.14 EPS for the quarter, beating the consensus estimate of $0.13 by $0.01. QuinStreet had a return on equity of 14.14% and a net margin of 4.60%. The company had revenue of $112.90 million for the quarter, compared to analyst estimates of $103.59 million. During the same period last year, the company posted $0.08 earnings per share. The firm’s revenue was up 29.2% compared to the same quarter last year.

A number of analysts have recently issued reports on the company. Craig Hallum reaffirmed a “buy” rating on shares of QuinStreet in a research report on Wednesday, October 31st. BidaskClub raised QuinStreet from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, December 4th. Zacks Investment Research raised QuinStreet from a “hold” rating to a “buy” rating and set a $19.00 target price on the stock in a research report on Wednesday, November 7th. ValuEngine lowered QuinStreet from a “buy” rating to a “hold” rating in a research report on Thursday, November 8th. Finally, William Blair assumed coverage on QuinStreet in a research report on Thursday, October 4th. They set an “outperform” rating on the stock. One analyst has rated the stock with a hold rating, six have given a buy rating and one has issued a strong buy rating to the company’s stock. QuinStreet currently has a consensus rating of “Buy” and a consensus price target of $17.79.

Shares of NASDAQ QNST traded down $0.70 during midday trading on Friday, reaching $15.20. 504,624 shares of the company’s stock were exchanged, compared to its average volume of 675,216. QuinStreet has a 52-week low of $8.24 and a 52-week high of $17.75. The firm has a market cap of $749.21 million, a price-to-earnings ratio of 47.50, a PEG ratio of 1.12 and a beta of 0.72.

In related news, CEO Douglas Valenti sold 38,320 shares of QuinStreet stock in a transaction dated Wednesday, September 12th. The stock was sold at an average price of $14.34, for a total value of $549,508.80. Following the completion of the transaction, the chief executive officer now directly owns 287,919 shares in the company, valued at $4,128,758.46. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director James R. Simons sold 2,605 shares of QuinStreet stock in a transaction dated Wednesday, October 17th. The stock was sold at an average price of $15.01, for a total value of $39,101.05. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 229,362 shares of company stock worth $3,606,074. Corporate insiders own 12.50% of the company’s stock.

A number of large investors have recently bought and sold shares of the stock. Marshall Wace LLP acquired a new position in QuinStreet in the third quarter worth about $3,802,000. Vanguard Group Inc. grew its stake in QuinStreet by 7.5% in the third quarter. Vanguard Group Inc. now owns 2,255,880 shares of the technology company’s stock worth $30,612,000 after purchasing an additional 158,003 shares in the last quarter. Legal & General Group Plc grew its stake in QuinStreet by 7.0% in the third quarter. Legal & General Group Plc now owns 77,926 shares of the technology company’s stock worth $1,049,000 after purchasing an additional 5,098 shares in the last quarter. Nordea Investment Management AB acquired a new position in QuinStreet in the third quarter worth about $4,072,000. Finally, Equitable Trust Co. grew its stake in QuinStreet by 12.1% in the third quarter. Equitable Trust Co. now owns 223,151 shares of the technology company’s stock worth $3,028,000 after purchasing an additional 24,125 shares in the last quarter. Institutional investors and hedge funds own 83.41% of the company’s stock.

About QuinStreet

QuinStreet, Inc, an Internet performance marketing company, provides customer acquisition services for its clients in the United States and internationally. It offers online marketing services to its clients in the form of qualified leads, inquiries, clicks, calls, applications, customers, display advertisements, or impressions through its Websites or third-party publishers.

See Also: Cash Flow

Get a free copy of the Zacks research report on QuinStreet (QNST)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for QuinStreet (NASDAQ:QNST)

Receive News & Ratings for QuinStreet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for QuinStreet and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

IslaCoin Price Hits $0.17 on Exchanges
IslaCoin Price Hits $0.17 on Exchanges
WP Carey Inc  Given Average Recommendation of “Hold” by Brokerages
WP Carey Inc Given Average Recommendation of “Hold” by Brokerages
Medtronic PLC  Given Consensus Recommendation of “Buy” by Analysts
Medtronic PLC Given Consensus Recommendation of “Buy” by Analysts
Zen Protocol Reaches 24 Hour Trading Volume of $240,660.00
Zen Protocol Reaches 24 Hour Trading Volume of $240,660.00
Zynerba Pharmaceuticals  Upgraded by Zacks Investment Research to Buy
Zynerba Pharmaceuticals Upgraded by Zacks Investment Research to Buy
Po.et Price Up 5.6% Over Last 7 Days
Po.et Price Up 5.6% Over Last 7 Days


© 2006-2019 Ticker Report